Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biocon Ltd. Capital/Financing Update 2025

Apr 22, 2025

61176_rns_2025-04-22_9dbc8eb8-2292-4e46-9d85-8dabb5c4f6dc.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [132 x 53] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T: 91 80 2808 2808 F: 91 80 2852 3423

CIN : L24234KA1978PLC003417

www.biocon.com

BIO/SECL/TG/2025-26/14

April 22, 2025

To,
The Secretary
BSE Limited
Department of Corporate Services
Phiroze Jeejeebhoy Towers,
Dalal Street,Mumbai – 400 001
To,
The Secretary
National Stock Exchange of India Limited
Corporate Communication Department
Exchange Plaza, Bandra Kurla Complex
Mumbai – 400 050
Scrip Code – 532523 Scrip Symbol - Biocon

Dear Sir/Madam,

Subject: Issue of Commercial Papers of Rs. 600 Crores

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our letter dated April 04, 2025, we wish to inform you that the Company has issued Commercial Papers (CP) of Rs. 600 Crores on private placement basis, on the terms and conditions given below:

Sl. No. Particulars Remarks
1 Issue Size Rs. 600 Crores
2 Whether proposed to be listed?
If yes, name of the stock exchange
Yes
Proposed to be listed on the
National Stock Exchange of India
Limited
3 Tenure of the instrument 161 days
4 Date of Allotment 22/04/2025
5 Date of Maturity 30/09/2025
6 Coupon/Interest offered 7.75%
7 Schedule ofpayment of coupon/interest andprincipal 30/09/2025
8 Charge/security,if any,created over the assets No
9 Issued in favor of SBI Mutual Fund - SBI Savings
Fund
10 Credit Ratings IND A1+
11 Special rights/ interest/ privileges attached to the
instrument and changes thereof
Not Applicable

==> picture [132 x 53] intentionally omitted <==

Sl. No. Particulars Remarks
12 Delay in payment of interest/ principal amount for a
period of more than 3 months from the due date or
default inpayment of interest/ principal
Not Applicable
13 Details
of
any
letter
or
comments
regarding
payment/non-payment of interest, principal on due
dates, or any other matter concerning the security and/or
the assets alongwith its comments thereon,if any
Not Applicable

The above-mentioned information will also be available on the website of the Company at www.biocon.com.

Kindly take the above information on record and acknowledge.

Thanking You,

For Biocon Limited

Digitally signed SIDDHART by SIDDHARTH MITTAL H MITTAL Date: 2025.04.22 20:06:28 +05'30'


Siddharth Mittal Managing Director & CEO DIN: 03230757